365 related articles for article (PubMed ID: 27329131)
1. Incidence and risk factors of herpes zoster in human immunodeficiency virus-positive patients initiating combination antiretroviral therapy in Taiwan.
Lee YC; Hung CC; Tsai MS; Zhang JY; Wu PY; Yang SP; Luo YZ; Chang HY; Liu WC; Sun HY; Chang SC
J Microbiol Immunol Infect; 2018 Feb; 51(1):38-44. PubMed ID: 27329131
[TBL] [Abstract][Full Text] [Related]
2. Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.
Grabar S; Tattevin P; Selinger-Leneman H; de La Blanchardiere A; de Truchis P; Rabaud C; Rey D; Daneluzzi V; Ferret S; Lascaux AS; Hanslik T; Costagliola D; Launay O;
Clin Infect Dis; 2015 Apr; 60(8):1269-77. PubMed ID: 25601456
[TBL] [Abstract][Full Text] [Related]
3. Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South Africa.
Shearer K; Maskew M; Ajayi T; Berhanu R; Majuba P; Sanne I; Fox MP
Int J Infect Dis; 2014 Jun; 23():56-62. PubMed ID: 24680820
[TBL] [Abstract][Full Text] [Related]
4. Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.
Lapadula G; Cozzi-Lepri A; Marchetti G; Antinori A; Chiodera A; Nicastri E; Parruti G; Galli M; Gori A; Monforte Ad;
AIDS; 2013 Mar; 27(5):769-79. PubMed ID: 23719349
[TBL] [Abstract][Full Text] [Related]
5. Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection.
Domingo P; Torres OH; Ris J; Vazquez G
Am J Med; 2001 Jun; 110(8):605-9. PubMed ID: 11382367
[TBL] [Abstract][Full Text] [Related]
6. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
[TBL] [Abstract][Full Text] [Related]
7. Immune Correlates of Herpes Zoster in People Living with HIV on Effective Antiretroviral Therapy.
Tovar Salazar A; McKhann A; Chen H; Bosch RJ; Weinberg A
AIDS Res Hum Retroviruses; 2019 Oct; 35(10):890-895. PubMed ID: 31179712
[TBL] [Abstract][Full Text] [Related]
8. Association between quantitative varicella-zoster virus antibody levels and zoster reactivation in HIV-infected persons.
Pomerantz HS; Xu X; White J; Sunil TS; Deiss RG; Ganesan A; Agan BK; Okulicz JF
AIDS Res Ther; 2018 Dec; 15(1):25. PubMed ID: 30537970
[TBL] [Abstract][Full Text] [Related]
9. Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.
Moanna A; Rimland D
Clin Infect Dis; 2013 Jul; 57(1):122-5. PubMed ID: 23487391
[TBL] [Abstract][Full Text] [Related]
10. Herpes zoster could be an early manifestation of undiagnosed human immunodeficiency virus infection.
Lai SW; Lin CL; Liao KF; Chen WC
J Formos Med Assoc; 2016 May; 115(5):372-6. PubMed ID: 26395527
[TBL] [Abstract][Full Text] [Related]
11. The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era.
Gebo KA; Kalyani R; Moore RD; Polydefkis MJ
J Acquir Immune Defic Syndr; 2005 Oct; 40(2):169-74. PubMed ID: 16186734
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy.
Gotti D; Danesi M; Calabresi A; Ferraresi A; Albini L; Donato F; Castelli F; Scalzini A; Quiros-Roldan E;
AIDS Patient Care STDS; 2013 May; 27(5):259-65. PubMed ID: 23600703
[TBL] [Abstract][Full Text] [Related]
13. Trends and the associated factors of optimal immunological response and virological response in late anti-retroviral therapy initiation HIV cases in Taiwan from 2009 to 2020.
Lee CY; Lin YP; Lin CY; Chen TC; Kuo SH; Lo SH; Wang SF; Lu PL
J Infect Public Health; 2024 Feb; 17(2):339-348. PubMed ID: 38194765
[TBL] [Abstract][Full Text] [Related]
14. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.
Wood SM; Shah SS; Steenhoff AP; Rutstein RM
Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820
[TBL] [Abstract][Full Text] [Related]
15. Impact of Antiretroviral Therapy on the Risk of Herpes Zoster among Human Immunodeficiency Virus-Infected Individuals in Tanzania.
Kawai K; Hawkins CA; Hertzmark E; Francis JM; Sando D; Muya AN; Ulenga N; Fawzi WW
Am J Trop Med Hyg; 2018 Feb; 98(2):396-401. PubMed ID: 29313475
[TBL] [Abstract][Full Text] [Related]
16. Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study.
Hung CC; Hsiao CF; Wang JL; Chen MY; Hsieh SM; Sheng WH; Chang SC
Int J STD AIDS; 2005 Oct; 16(10):673-6. PubMed ID: 16212714
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral therapy initiation in an Australian cohort: implications for increased use of antiretroviral therapy.
Stratov I; Kent SJ
Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):253-9. PubMed ID: 25139203
[TBL] [Abstract][Full Text] [Related]
18. Zoster incidence in human immunodeficiency virus-infected hemophiliacs and homosexual men, 1984-1997. District of Columbia Gay Cohort Study. Multicenter Hemophilia Cohort Study.
Engels EA; Rosenberg PS; Biggar RJ
J Infect Dis; 1999 Dec; 180(6):1784-9. PubMed ID: 10558932
[TBL] [Abstract][Full Text] [Related]
19. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
Panel de expertos de GESIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
[TBL] [Abstract][Full Text] [Related]
20. Etiology of pulmonary complications of human immunodeficiency virus-1-infected patients in Taiwan in the era of combination antiretroviral therapy: a prospective observational study.
Lee KY; Ho CC; Ji DD; Lee CM; Tsai MS; Cheng AC; Chen PY; Tsai SY; Tseng YT; Sun HY; Lee YC; Hung CC; Chang SC
J Microbiol Immunol Infect; 2013 Dec; 46(6):433-40. PubMed ID: 23026388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
